Nanosphere to Release Second Quarter Results and Host Investor Conference Call on Wednesday, August 6, 2014

Nanosphere to Release Second Quarter Results and Host Investor Conference Call
on Wednesday, August 6, 2014

NORTHBROOK, Ill., July 23, 2014 (GLOBE NEWSWIRE) -- Nanosphere, Inc.
(Nasdaq:NSPH), a company enhancing medicine through targeted molecular
diagnostics, today announced that it will report its results for the second
quarter of 2014 on Wednesday, August 6, 2014. The company will also hold a
live investor conference call and webcast at 5:00pm Eastern/2:00pm Pacific.

Conference Call & Webcast
Wednesday, August 6, 2014 @ 5:00pm Eastern Time/2:00pm Pacific Time
Domestic:                        888-428-9480
International:                   719-325-2402
Passcode:                        3611525
Webcast:                         www.nanosphere.us
                                
Replays – Available through August 20, 2014
Domestic:                       877-870-5176
International:                  858-384-5517
Passcode:                       3611525

About Nanosphere, Inc.

Nanosphere is enhancing medicine through targeted molecular diagnostics that
result in earlier disease detection, optimal patient treatment and improved
healthcare economics. The Company's versatile technology platform, the
Verigene® System, enables clinicians to rapidly detect the most complex,
costly and deadly infectious diseases through a low cost and simple-to-use
multiplexed diagnostic test. The combination of this innovative technology and
Nanosphere's customer-driven solutions keeps commitment to the patient at the
forefront of its business. Nanosphere is based in Northbrook, IL. Additional
information is available at http://www.nanosphere.us.

Except for historical information, the matters discussed in this press release
are "forward-looking statements" and are subject to risks and uncertainties.
Actual results could differ materially from these forward-looking statements.
Factors that could cause or contribute to such differences include, but are
not limited to, the following: (i) Nanosphere's ability to develop
commercially viable products; (ii) Nanosphere's ability to achieve
profitability; (iii) Nanosphere's ability to produce and market its products;
(iv) Nanosphere's ability to obtain regulatory approval of its products; (v)
Nanosphere's ability to protect its intellectual property; (vi) competition
and alternative technologies; and (vii) Nanosphere's ability to obtain
additional financing to support its operations. Additional risks are discussed
in the Company's current filings with the Securities and Exchange Commission.
Although the Company believes the expectations reflected in such
forward-looking statements are based on reasonable assumptions, it can give no
assurance that its expectations will be attained. The forward-looking
statements are made as of the date of this press release, and we undertake no
obligation to publicly update or revise any forward-looking statement, whether
as a result of new information, future events or otherwise.

CONTACT: Investors:
         Roger Moody
         Chief Financial Officer
         Nanosphere, Inc.
         847-400-9021
         rmoody@nanosphere.us
        
         Michael Rice
         Founding Partner
         LifeSci Advisors
         646-597-6979
         mrice@lifesciadvisors.com
        
         Media:
         Lindsey Saxon
         Director of Communications
         Nanosphere, Inc.
         847-400-9173
         lsaxon@nanosphere.us

Nanosphere, Inc. logo
 
Press spacebar to pause and continue. Press esc to stop.